Korro Bio, Inc. (KRRO) financial statements and ratios from SEC XBRL: revenue $6.39M (TTM), net margin -1834.5%, revenue growth 181.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $6.39M |
| Net Margin | -1834.5% |
| Revenue Growth (YoY) | 181.5% |
| EPS Growth (YoY) | 33.2% |
| FCF Growth (YoY) | 1.4% |
| Price / Book | 1.87 |
| Price / Sales | 177.52 |
| FCF Yield | -65.4% |
| Altman Z-Score | -5.64 (distress) |
| Sector P/E (Healthcare) | 21.7 |
KRRO overview · KRRO earnings · KRRO KPIs · KRRO investor relations · KRRO ownership · KRRO peers · KRRO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.